Avantis Real Estate ETF AVRE 深 滬
已收盤 08-08 16:00:00 美东时间
43.96
-0.210
-0.48%
華盛通- 最 高44.29
- 今 開44.29
- 成交量 3.08万股
- 最 低 43.93
- 昨 收 44.17
- 總市值 6.00亿
- 52周最高 46.6331
- 市盈率 靜 --
- 換手率 0.23%
- 52周最低 37.3111
- 委 比 -12.50%
- 總股本 1364.00万
- 歷史最高 51.2171
- 量 比 0.55
- 振 幅 0.82%
- 歷史最低 32.1971
- 每 手 1
- 風險率 3.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
GAVRETO will be available from Rigel in the U.S. beginning June 27, 2024 SOUTH SAN FRANCISCO, Calif., June 24, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today...
2024-06-25 04:05
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
GAVRETO® (pralsetinib) is an FDA approved targeted therapy for the treatment of RET fusion-positive metastatic non-small cell lung cancer and advanced or metastatic thyroid cancer Acquisitio...
2024-02-22 20:50
Blueprint Medicines Highlights 2024 Corporate Strategy and Business Priorities at 42nd Annual J.P. Morgan Healthcare Conference
-- AYVAKIT® (avapritinib) launch in indolent systemic mastocytosis to drive strong revenue growth in 2024, with ongoing U.S. launch and recent EU approval -- -- Expanding mast cell disease l...
2024-01-08 21:00
AVANTIS LAUNCHES U.S. LARGE CAP EQUITY ETF
KANSAS CITY, Mo., Sept. 28, 2023 /PRNewswire/ -- Avantis Investors®, a $27 billion* investment offering from global asset manager American Century Investments®, further expands its investmen...
2023-09-28 21:32
AVANTIS INVESTORS LAUNCHES FOUR NEW ACTIVE ETFS
KANSAS CITY, Mo., June 29, 2023 /PRNewswire/ -- Today, Avantis Investors®, a $25 billion* investment offering from global asset manager American Century Investments®, expands its exchange tr...
2023-06-29 22:00
